Medical supplies contracts in Germany

1,508 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Biperiden (excluding strength 4 mg), ATC N04AA02, for the period 01.09.26 – 31.08.28 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 495070-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Betamethasone + Clotrimazole, ATC D01AC20 for the period 01.09.2026 - 31.08.2028 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 496714-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Cefixime (excluding Dafo. FTA), ATC J01DD08 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495268-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lidocaine, ATC N01BB02 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495164-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Perampanel, ATC N03AX22 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496953-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brinzolamide + Brimonidine, ATC S01EC24 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495328-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Perindopril arginine + Amlodipine + Indapamide, ATC C09BX01, for the period 01.9.26–31.8.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495404-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Capsaicin, ATC N01BX04, for the period 01.09.2026–31.08.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 496025-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Oxybutynin (excluding Dafo. PFT), ATC code G04BD04 for the period from 01.09.26 to 31.08.28 (including V.-option for 1x12 months)

DAK-Gesundheit, HamburgTED 494810-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Miconazole + Fluprednidene, ATC D01AC20 for the period 01.09.2026 - 31.08.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495339-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Clotrimazole + Hydrocortisone, ATC D01AC20, for the period 01.09.2026–31.08.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495637-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Cefadroxil (excluding Dafo. TAB), ATC J01DB05, for the period 01.09.2026–31.08.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 495513-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Hydrocortisone (excluding Dafo. TVW), ATC H02AB09 for the period 01.09.26 - 31.08.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 496057-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement under § 130a, para. 8 of the German Social Security Code (SGB V) for the active substance Olanzapine (excluding Dafo. TRS), ATC code N05AH03 for the period 01.09.2026 - 31.08.2028 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 494411-2026

€11 lot, 2 years

Thu 5 Jul12:00 in Berlin

980days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Budesonide + Formoterol (excluding IHP in the strength 80 µg/4, 5 µg), ATC R03AK07 for the period 1.10.26 - 30.09.28

DAK-Gesundheit, HamburgTED 569675-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Piracetam, ATC N06BX03 for the period 01.10.2026 - 30.09.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 570333-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Betahistine (excluding strengths 6 mg and 12 mg) for the period 01.10.2026 – 30.09.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 570684-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Dydrogesterone, ATC G03DB01, for the period 01.10.2026 – 30.09.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 571940-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Brimonidine (excluding DaFo single doses), ATC S01EA05 for the period 01.10.26 - 30.09.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 569456-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Baclofen (excluding oral Dafo.), ATC M03BX01 for the period 01.10.26 - 30.09.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 569918-2026

€11 lot, 2 years

Sun 5 Aug12:00 in Berlin

1011days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.